Carbonic adsorbent AST-120 retards progression of renal failure by additive effect with ACEI and protein restriction diet

Clinical and Experimental Nephrology

Volumn 7, Issue 2, 2003, Pages 113-119

  Imai, Enyu ^a   Takenaka, Masaru ^a   Isaka, Yoshitaka ^a   Moriyama, Toshiki ^a   Akagi, Yoshitaka ^a   Kakuchi, Jyunji ^b   Fujii, Takashi ^a   Ito, Takahito ^a   Hori, Masatsugu ^a   Horio, Masaru ^c   Syoji, Tatsuya ^d   Tsubakihara, Yoshiharu ^d  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KUREHA CORPORATION   (Japan)

^c OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^d OSAKA GENERAL MEDICAL CENTER   (Japan)

Author keywords

Chronic renal failure; Glomerulosclerosis; Low protein diet; Nutrition; Tubulointersitial fibrosis

Indexed keywords

ABSORBENT; AST 120; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; HISTOPATHOLOGY; KIDNEY FUNCTION; MALE; NONHUMAN; PROTEIN RESTRICTION; RAT; SURVIVAL RATE; SURVIVAL TIME;

ADSORPTION; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD PRESSURE; CAPTOPRIL; CARBON; DIET, PROTEIN-RESTRICTED; DRUG THERAPY, COMBINATION; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE; NEPHRECTOMY; OXIDES; PROTEINURIA; RATS; RATS, SPRAGUE-DAWLEY; SURVIVAL RATE;

EID: 10744224475     PISSN: 13421751     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10157-002-0220-0     Document Type: Article

References (17)

1. Aoyama I, Shimokata K, Niwa T. Oral adsorbent AST-120 ameliorates interstitial fibrosis and transforming growth factor-beta 1 expression in spontaneously diabetic (OLETF) rats. Am J Nephrol 2000;20:232-41.
2. Yoshida Y, Sakai T, Ise M. Effects of oral adsorbent in the rat model of chronic renal failure. Nephron 1992;62:305-14.
3. Sanaka T, Sugino N, Teraoka S, Ota K. Therapeutic effect of oral sorbent in undialyzed uremia. Am J Kidney Dis 1988;12:97-103.
4. Owada A, Nakao M, Koike J, Ujiie K, Tomita K, Shiigai T. Effects of oral adsorbent AST-120 on the progression of chronic renal failure: a randomized controlled study. Kidney Int Suppl 1997;63: S188-90.
5. Kasiske B, Kalil R, Ma J, Liao M, Keane WF. Effect of antihypertensive therapy on the kidney in patients with diabetes: a metaregression analysis. Ann Intern Med 1993;118:129-38.
6. Maschio G, Alberti D, Janin G, Locatelli F, Mann JF, Motolese M, et al. Effect of angiotensin converting enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med 1996;334:939-45.
7. GISEN group. Randomized placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric and non-diabetic nephropathy. Lancet 1998;349:1857-63.
8. Pedrini M, Levey A, Lau J, Chalmers TC, Wang PH. The effect of dietary protein restriction on the progression of diabetic and non-diabetic renal diseases: a meta-analysis. Ann Intern Med 1996;124:627-32.
9. Laouari D, Kleinknecht C. The role of nutritional factors in the course of experimental renal failure. Am J Kidney Dis 1985;5:147-56.
10. Bras G, Ross M. Kidney disease and nutrition in the rat. Toxicol Applied Pharmacol 1964;6:247-62.
11. Kleinknecht C, Laouari D, Hinglais N, Habib R, Dodu C, Lacour B, et al. Role of amount and nature of carbohydrates in the course of experimental renal failure. Kidney Int 1986;30:687-93.
12. Akagi Y, Isaka Y, Arai M, Kaneko T, Takenaka M, Moriyama T, et al. Inhibition of TGF-β1 expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int 1996;50:148-55.
13. Isaka Y, Tsujie M, Ando Y, Nakamura H, Kaneda Y, Imai E, et al. Transforming growth factor-β1 antisense oligodeoxynucleotides block interstitial fibrosis in unilateral ureteral obstruction. Kidney Int 2000;58:1885-92.
14. Niwa T, Ise M, Miyazaki T. Progression of glomerular sclerosis in experimental uremic rats by administration of indole, a precursor of indoxyl sulfate. Am J Nephrol 1994;14:207-12.
15. Miyazaki T, Aoyama I, Ise M, Seo H, Niwa T. An oral sorbent reduces overload of indoxyl sulphate and gene expression of TGF-beta1 in uraemic rat kidneys. Nephrol Dial Transplant 2000;15:1773-81.
16. Miyazaki T, Ise M, Hirata M, Endo K, Ito Y, Seo H, et al. Indoxyl sulfate stimulates renal synthesis of transforming growth factor-β1 and progression of renal failure. Kidney Int Suppl 1997;63:S211-4.
17. Aoyama I, Shimokata K, Niwa T. Combination therapy with benazepril and oral adsorbent ameliorates progressive renal fibrosis in uremic rats. Nephron 2002;90:297-312.